FDA OKs Hizentra for rare autoimmune disease CIDP
Just one day after getting cleared to sell its new rare disease drug Hizentra in Europe, Pennsylvania drugmaker CSL Behring got the green light from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.